An experimental treatment improves the cognitive ability and gut microbiota of mice with fragile X syndrome
Ongoing treatment with a drug that inhibits the endocannabinoid system peripherally improves memory deficits, reduces synaptic alterations, mitigates gut microbiota dysbiosis and restores intestinal barrier integrity markers ...
9 hours ago
0
3









